Evusheld long-acting antibody combination retains neutralising activity against Omicron variant in independent FDA study Read more
Swarnajayanti fellow from CDRI probing mitochondrion of malaria parasite for hints into alternative drug targets Read more
Zydus to begin phase-II (a) clinical trial of oral inflammasome inhibitor in patients with Cryopyrin-Associated Periodic Syndrome in Australia Read more
Zydus announces EPICS-IIITM phase-II(b)/III adaptive pivotal clinical trial of Saroglitazar Mg in PBC Read more